180 Life Sciences Corp. (ATNF)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 09:32AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.55M |
| Enterprise value | 630.31k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.36 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.03 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.44 |
| 52-week change 3 | -91.52% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 27.9300 |
| 52-week low 3 | 1.3300 |
| 50-day moving average 3 | 2.9412 |
| 200-day moving average 3 | 7.7018 |
Share statistics
| Avg vol (3-month) 3 | 107.25k |
| Avg vol (10-day) 3 | 108.92k |
| Shares outstanding 5 | 852.77k |
| Implied shares outstanding 6 | 913.68k |
| Float 8 | 765.12k |
| % held by insiders 1 | 3.35% |
| % held by institutions 1 | 11.20% |
| Shares short (15 Apr 2024) 4 | 17.08k |
| Short ratio (15 Apr 2024) 4 | 0.16 |
| Short % of float (15 Apr 2024) 4 | 2.04% |
| Short % of shares outstanding (15 Apr 2024) 4 | 2.00% |
| Shares short (prior month 15 Mar 2024) 4 | 61.83k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:19 |
| Last split date 3 | 28 Feb 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -67.63% |
| Return on equity (ttm) | -355.47% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -13.37M |
| Net income avi to common (ttm) | -19.94M |
| Diluted EPS (ttm) | -52.5900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.98M |
| Total cash per share (mrq) | 2.32 |
| Total debt (mrq) | 1.05M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.72 |
| Book value per share (mrq) | -0.24 |
Cash flow statement
| Operating cash flow (ttm) | -10.92M |
| Levered free cash flow (ttm) | -6.09M |
© 2024 Yahoo. All rights reserved.